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Preface
Census fi g u res indicate that there are some 50,000 centenarians in the UnitedStates and that there could be more than
800,000 by mid-century. One startling projection
is that there could be five million by the end of 
the century. There are even those in the so-called
anti-aging movement who suggest that we 
can one day achieve decades to hundreds of years 
of additional life.
Longevity genes have been identified in yeast,
worms, fruit flies, and mice, in some instances
with possible homology with humans; however
the term “longevity gene” itself is subject to 
question. Perhaps it refers to genes that extend
life beyond what is presently considered the 
maximum life span. Or perhaps longevity genes
only refer, in the most general sense, to biological
vigor over time, starting at the very beginning 
of life. These genes might direct resistance to
internal and external damage, such as those that
result from free radicals and glycation. Perhaps
they control rapid and effective repair.
The International Longevity Center and its 
sponsors assembled a group of leading scientists
who have contributed to the growing field of
what may best be called “longevity science”
(as it is in Japan).The purpose of this workshop
was to reach a consensus on what we currently
know about longevity. The participating scientists
w e re asked to re c ommend a re s e a rch agenda,
suggest what should be re s p on s i b ly told to 
the public, and delineate policy implica t i ons for 
b u s i n e s s , f o u n d a t i on s , and gove rn m e n t . T h i s
re p o rt discusses their con cl u s i on s .
Robert N. Butler, M.D.
President and CEO
International Longevity Center-USA
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A variety of lines of evidence indicate thataging and longevity are subject to geneticregulation, but until fairly recently the 
identity of these genes was unknown.This has
changed dramatically over the last 10 years as
investigators have taken advantage of both inver-
tebrate and vertebrate model systems to study
longevity genes. Invertebrates include nematodes
(roundworms) and fruit flies. Early success with
nematodes has been quickly followed up in fruit
flies, and even studies in mice are beginning to
identify “longevity genes.” The ultimate purpose
of this research is to determine whether similar
genes are factors in regulating lon g ev i ty and timing
development of aging phenotypes in humans.
The strongest rationale for believing that genes 
as well as env i ronmental and behavioral factors
can influence the rate of aging within a species
was provided by the demon s t ra t i on that it 
is possible to select for lon g - l i ved strains of 
f ruit flies. With re g a rd to fruit flies, s c i e n t i s t s
have identified a variety of single gene mutations 
that either increase their life expectancy or 
modify the extension of life expectancy by 
other mutations.
Mice provide a very useful model system for a
bridge between invertebrates and humans because
of their more complex anatomy and our know l e d g e
of their physiology and metabolism. At least 
four distinct genes have been identified in which
loss-of-function mutations lead to dwarfism and
increased mean and maximum longevity.
Experimentally, longevity genes are usually
identified by showing that full or partial ablation
of the gene, or overexpression of the gene,
alters life expectancy. Longevity genes can be
sorted into a variety of theoretical categories for
the purpose of better understanding what 
role(s) they play in human aging.
Genes that cause aging. Most gerontologists
believe there are no such genes because a gene
that promotes aging would most likely decrease
reproductive fitness and, therefore, be subject 
to negative selection.
Genes that affect what kind of old individual 
you are. Thousands of these genes are present in
mice and humans. The polymorphic differences
(alleles) help to determine which and how soon
individuals will become gray or bald or develop
specific pathologies such as osteoporosis, macular
degeneration, or cognitive impairment. However,
this is not the same as saying that these genes
actually regulate the rate of aging.
Genes that extend life expectancy or maximum
life span. These genes affect processes such as
re s p onse to growth horm on e, insulin-like signaling,
and response to stress; in doing so they influence
life expectancy in a wide range of organisms.
Such genes were first found in model systems,
e s p e c i a lly in nematodes and fruit flies, but examples
in mice are starting to appear. Alleles of this 
sort probably exist in humans, but they are harder
to demonstrate in this long-lived species than 
in short-lived animal models.
Executive Summary
R o b e rt N. B u t l e r, M . D.
President and CEO, I n ternational Longev i ty Center
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Na tu ra lly occurring alleles and allele combinati o n s
that alter life ex pe c t a n cy because they affect aging.
If there are any polym o rphic genetic loci that
influence aging rate within a species, t h ey pro b a b ly
include a large number with very small effects
and at least a few with detectably large effects.
At least five such loci have already been detected
in mice. It is hoped that mice such as these will
be part i c u l a rly useful for understanding genetic
factors affecting the aging pro c e s s .
Candidate genes assumed to influence the rate 
of aging because of the function of the proteins
coded by these genes. Examples of these ca n d i d a t e
genes include genes coded for proteins that
either repair or prevent damage to cellular 
components. Naturally occurring alleles of such
genes could alter the rate of aging under at least
some conditions. Examples of such genes are
found in mice, and it is expected that similar
genes will usually influence longevity in humans.
Human examples might include genes for 
DNA repair and antioxidant defense systems.
Genes that influence life expectancy differences
among species. These are the real longevity
genes of interest and should explain the wide 
differences in the rate of aging among diverse
species such as nematodes, fruit flies, mice, and
humans. Although no genes in this category
have yet been unequivocally identified, it 
has been posited that these genes will regulate
the pace of multiple deve l o pmental and degenera t i ve
processes, much as caloric restriction appears 
to do but to a much greater extent.
RELEVANCE TO HUMAN AGING
Major questions arising from these studies with
animal models are:
1. Can these results be extrapolated to humans?
2. If so, will this information lead to the 
development of safe and effective nongenetic
interventions to delay some of the adverse
aspects of aging in humans or at least provide
clues about modulating mechanisms of aging 
in humans?
3. What other genes can be mutated or over-
exp ressed to produce delayed aging, and does 
n a t u ra l variation at these loci influence the rate 
of aging and risk of developing aging ph e n o typ e s ?
4. Most importantly, do any of the loci where
null mutations greatly extend longevity in model
systems provide leads to the genetic differences
responsible for the much greater aging rate 
differences among species?
RESEARCH AGENDA
The ultimate payoff for this genetic research is 
to learn enough about aging to identify prom i s i n g
avenues for nongenetic interventions to delay,
prevent, or even reverse the adverse age-related
changes leading to disease and disability in
humans. Workshop participants particularly
emphasized the need to develop approaches to
identify human longevity genes.This will require
the recruitment of centenarians and their 
long-lived sibs and long-lived multigenerational 
families for genetic analysis. Other areas include
research to identify the molecular basis for
increased life expectancy induced by caloric
restriction; identify reliable biomarkers of aging;
expand understanding of why some species 
either escape aging or appear to be longer-lived
than expected; develop new mammalian models
to facilitate discove ry of genetic factors that 
i n f l u e n c e the rate of aging and life expectancy,
as well as the risk for age-related disease;
identify the environmental and behavioral factors
that account for up to an estimated 70 percent 
of the risk factors for aging.
T
he strongest rationale for believing that not
only environmental and behavioral factors
but also genes can inf luence the rate of
aging of individuals within a species was provided
by the demonstration that it is possible to select
for long-lived strains of fruit f lies (Luckinbill
et al. 1984; Rose 1984). Such genes have been
variously called longevity-assurance genes,
longevity-enabling genes, longevity-associated
genes, longevity genes, or gerontogenes. For the
purpose of the workshop and this report, the 
term “longevity genes” is used. Because longevity
genes may mean different things to different 
people, it is important to sort out the nuances 
of different kinds of genes at the beginning.
Longevity genes may manifest themselves in a
variety of ways, including:
• Full or partial ablation may increase or decrease
life expectancy, or
• Overexpression of the gene or a particular allele
may increase or decrease life expectancy.
Whereas the overexpression or ablation of almost
a ny gene may decrease life expectancy, the intention
here is to focus on genetic changes that increase
life expectancy, or shorten life expectancy if they
do so with indications of premature aging.
Examples of such genes associated with altera t i on s
of life expectancy are found in Tables 1, 2, and 3.
Workshop participants suggested that these genes
be sorted into distinct theore t i cal ca t e go ri e s . Seve n
ca t e go ries are described below with com m e n t s ,
where appropriate, about the nature and quantity
of human genes that might be found in these 
categories.
Although the genes of primary interest for 
understanding aging are the ones that increase life
expectancy when either overexpressed or mutated,
other genes may be informative about a variety of
age-related changes that inf luence life expectancy
in other ways. It is important to recognize
that there are only a few traits in the invertebrate 
s ystems that can be used as a measure of organismic
aging. Thus, the best measure of retarded aging 
in invertebrate systems is usually increased
life expectancy. In contrast, age-related changes in
disease risk can be evaluated in mammals, so it
might be somewhat easier to distinguish between
genes that inf luence mammalian life expectancy
by altering the rate of aging globally and those
that only regulate some aspects of aging and may
or may not also inf luence life expectancy.
GENES THAT “CAUSE” AGING 
This ca t e go ry includes genes that ev o lved to bri n g
about the aging pro c e s s . Most gerontologists believe
t h e re are no such genes in most species, i n cl u d i n g
h u m a n s , b e cause a gene that promotes aging 
would most likely decrease re p ro d u c t i ve fitness and 
t h e re f o re would be subject to negative selection .
GENES THAT ALTER LONGEVITY BECAUSE
THEY MODULATE THE RISK OF EARLY-LIFE
PATHOLOGY AND DISEASE 
Genes that cause or increase the risk of pathology
or disease may lead to a dramatic diminution
of life span but are unlikely to provide important
insights into aging. Therefore, while there may
Introduction
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2be a large number of such genes, they should 
only be considered to be longevity genes if it can
be shown that mutant alleles accelerate multiple
aspects of aging. This may not be an easy task.
For example, the complete absence of superoxide
dismutase 2 (SOD2), the SOD form found in
mitochondria, causes mice to die of dilated car-
diomyopathy less than one month after birth 
(Li et al. 1995). Because these animals die very
young with atypical pathology, the Sod2 gene
would only be considered a true longevity gene if
it could be shown that reduced levels of SOD2
accelerate the usual aging-induced adverse
changes. Knock-out mice heterozygous for Sod2
do show altered mitochondrial function and
increased sensitivity of cardiomyocytes to apop-
tosis-inducing agents, but this is not necessarily
accelerated aging, and the life expectancy of these
mice is normal (van Remmen et al. 2001).
A possibly more appro p riate example is the Klotho
gene in mice (Kuro-o et al. 1997). A mutation in
this gene does lead to various pathologies associ-
ated with aging in humans, such as atherosclerosis
and osteoporosis, and therefore studying Klotho
mutants may be informative about human aging.
Human genes 
There are probably a good many genes that affect
the risk of ear ly-life pathology and disease.
Examples include tumor-suppressor genes RB
and BRCA1, the Hutchinson-Gilford gene, and 
a whole host of mutated genes responsible 
for the so-called inborn errors of metabolism.
Few, if any, of these should be considered to be
true longevity genes. For example, the growth 
and development of children with Hutchinson-
Gilford syndrome is usually affected by the end 
of the first year of life, and these children have
premature cardiovascular disease and often die of
heart attacks in their midteens. While studying
such a gene might provide important clues about
aging, it seems clear that this is not premature
aging per se (Mills and Weiss 1990); for example,
many aspects of aging, such as neurodegeneration,
are not seen in these children. Human DNA does
contain a homologue of the mouse Klotho gene,
but it is unknown whether it is associated with
human aging.
GENES THAT AFFECT WHAT KIND OF 
OLD INDIVIDUAL YOU ARE 
There are thousands, perhaps tens of thousands,
of these genes in mice and humans. Such genes
might be more difficult to identify in inverte-
brates because death is not currently associated
with well-characterized pathology.
Human genes 
The differences in these genes among humans
help to determine which and how soon individuals
will become gray or bald or develop specific
pathologies such as osteoporosis, macular degen-
eration, Type II diabetes, sarcopenia, cognitive
impairment, immune senescence, or a raft of
other complaints. George Martin has described
these as loci where mutations produce one or
more changes in old people and are thus age-
related (Martin 1978). This is not the same as
saying that these loci regulate the aging process.
A few examples of these are listed in Table 4.
Single nucleotide polymorphisms are proving
informative in detecting these genes. An excellent
example is the APOE locus where the alleles have
a strong inf luence on the risk for early onset of
Alzheimer’s disease (Schachter et al. 1994), car-
diovascular disease, and perhaps other diseases
(Makley and Rall 2000).
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3GENES THAT EXTEND LIFE EXPECTANCY OR
MAXIMUM LIFE SPAN 
Such genes are being increasingly found in model
systems, especially nematodes (Table 1) and fruit
f lies (Table 2), and examples in mice are also
starting to appear (Table 3). These genes affect
processes such as response to growth hormone,
insulin-like signaling, and response to stress; in so
doing, they inf luence life expectancy in a wide
range of organisms (Table 5). These lon g ev i ty genes
may also inf luence aging per se, by regulating
pathways that influence the rate of aging, but data
showing this are scarce. The best documented
example is the Snell (Pit1dw) dwarf mutant mouse
(Flurkey et al. 2001), which is not only long-lived
but also shows delayed development of both age-
sensitive immunological changes (cellular aging)
and collagen cross-linking (extracellular aging),
as well as deceleration of both lethal illness and
incidental pathology such as arthritic changes.
The value of studying these genes and their alleles
lies in the hope that they will provide revealing
glimpses of the control panel by which aging can
be regulated.The specific pathways, both 
biochemical and cellular, altered by mutations in
these genes may be the ones nature uses to 
produce long-lived species and/or individuals.
Human genes 
Alleles of this sort exist in humans, but they are
harder to demonstrate in this long-lived species
than in short-lived animal models. It is reasonable
to assume they will modulate the processes listed
in Table 5; examples include the PROP1 and
GHR genes. The best way to identify these genes
may be to first identify them in invertebrate and
mammalian models.
N AT U R A L LY OCCURRING ALLELES AND 
ALLELE COMBINATIONS THAT ALTER LIFE
E X P E C TANCY BECAUSE THEY AFFECT AG I N G
If there are any polymorphic genetic loci that
i nf luence aging rate within a species, t h ey pro b a b ly
include a large number with very small effects and
at least a few with detectibly large effects. At least
five such loci have already been detected in mice,
segregating in a four-way cross derived from
four common mouse stocks: BALB/c, C57BL/6,
DBA/2 and C3H/He, although the gene prod-
ucts corresponding to these loci are not known
(Miller et al. 2000; Jackson et al. 2002). It is
hoped that mice such as these will be particularly
useful for asking questions about the genetics 
of aging rather than the genetics of longevity, but
this will depend on whether or not the alleles in
q u e s t i on influence lon g ev i ty by means of a genera l
effect on multiple forms of late-life vulnerability.
Although the relevant genes have not been 
identified, the differences in life expectancy
between mainland and island opossums (Austad
1993) may be explained by these genes.
Human genes 
If such genes exist in mice, they will also exist 
and can be identified in humans. A possible
example is the gene that causes Werner’s
Syndrome (WRN) when mutated (Epstein et al.
1966; Yu et al. 1996; Martin and Oshima 2000).
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CANDIDATE GENES ASSUMED TO INFLUENCE
THE RATE OF AGING BECAUSE OF THE 
FUNCTION OF THE PROTEINS CODED BY
THESE GENES  
Examples include genes coding for proteins that
either repair or prevent damage to cellular 
components. Naturally occurring alleles of such
genes could alter the rate of aging under at least
some conditions. A possible specific example for
this category is the gene for methionine sulfoxide
reductase (Moskovitz et al. 2001). The role of 
this gene is to convert oxidized methionines on
the surface of proteins back to their normal state.
C omplete ablation of this activity in mice short e n s
life expectancy by about 40 percent. Because of
this, and because oxidative stress is thought to be
a risk factor for aging, it is reasonable to assume
that partial loss of methionine sulfoxide re d u c t a s e
a c t i v i ty could have small effects on the rate of aging
if natura lly occurring alleles coding for a pro t e i n
with decreased activity do exist. A more conv i n c i n g
e x p e riment would be to show that ove re x p re s s i on 
of the gene increases life expectancy.
Human genes 
If such genes exist in mice, it is expected that
similar genes will usual ly inf luence longevity in
humans. Human examples might include genes
for DNA repair and antioxidant defense systems.
GENES THAT INFLUENCE LIFE EXPECTANCY
DIFFERENCES AMONG SPECIES 
These are the real longevity genes of interest and
should explain the wide differences in the rate 
of aging among diverse species such as nema-
todes, fruit f lies, mice, and humans.They should
also explain why similarly sized rodents and 
birds (e.g., rats, pigeons) and different species of
rodents or fish (e.g., mouse vs. naked mole rat)
sometimes have anomalous life expectancies. No
genes in this category have yet been unequivocally
identified, but it is posited that these genes will
regulate the pace of multiple developmental and
degenerative processes much as caloric restriction
appears to do but to a much greater extent
(Weindruch and Walford 1988). Well-designed
comparative studies and perhaps a good deal of
luck will be required to unequivocally identify
these genes.
4
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BIOCHEMICAL
GENE FUNCTION COMMENTS REFERENCES
daf-2
age-1
(daf-23)
sir-2
eat-2 and
o t h e r eat
mutants
daf-16
old-1 and
o l d - 2
c l k - 1
c t l - 1
m ev - 1
Insulin/IGF-I-like
receptor
PI-3-kinase 
activity
NAD+ dependent
histone 
deacetylase
Unknown
Transcription 
factor
Receptor tyrosine
kinases
Mitochondrial
polypeptide 
similar to yeast
COQ7
Catalase
Cytochrome b in
mitochondrial
complex II
First step in insulin-like signaling pathway; muta-
tions increase life expectancy; the mutation need
occur only in neurons to achieve extension of life
expectancy.
Operates in insulin-like signaling pathway; mutations
increase life expectancy; activates Akt kinases;
increases levels of catalase and superoxide 
dismutase a c t i v i t i e s .
Overexpression increases life expectancy; sir-2 yeast
mutants are short - l i v e d .
Mutations cause defects in pharyngeal function and
m ay mimic caloric restriction; eat-2 further extends
the life expectancy of daf-2, but not clk-1, m u t a n t s .
Expression required for life expectancy extension by
d a f - 2 , d a f - 2 3 , and old-1 mutations; ov e r e x p r e s s i o n
increases life expectancy and resistance to stress.
Overexpression increases life expectancy and posi-
tively modulates resistance to stress; form e rly known
as tkr-1 and tkr-2; not closely related to daf-2.
Mutants are unable to synthesize coenzyme Q9, b u t
are long-lived when fed E. coli that supply coenzyme
Q8; overexpression shortens life expectancy.
Activity is required for increased life expectancy
induced by daf and clk mutations; ctl-1 mutants are
s h o rt - l i v e d .
Increased production of superoxide anion by complex
II and shortened life expectancy.
Kenyon et al. 1993
Larsen et al. 1995
Kimura et al. 1997
Wolkow et al. 2000
Johnson 1990
Larsen 1993
Morris et al. 1996
Tissenbaum and Guarente 2001
Lakowski and Hekimi 1998
Lin et al. 1997
Lin et al. 2001
Murakami and Johnson 2001
Murakami and Johnson 1998
Rikke et al. 2000
Johnson et al. 2000
Lakowski and Hekimi 1996
Felkai et al. 1999
Jonassen et al. 2001
Taub et al. 1999
Senoo-Matsuda et al. 2001
Longevity Genes Identified
in the Nematode (C. elegans)
Table 1
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BIOCHEMICAL
GENE FUNCTION COMMENTS REFERENCES
drop-
dead
InR
chico
Indy
hsp70
sod1
mth
Pcmt
Unknown
Insulin/IGF-I-like
receptor
Insulin receptor
substrate
Dicarboxylic acid
transport protein
Heat shock 
protein
C u / Z n - s u p e r o x i d e
dismutase
Transmembrane
protein
Protein carboxyl
methyltrans-
ferase
Mutations lead to acceleration in age-related
changes in gene expression and early death.
Fi rst step in insulin-like signaling pathway; mutations
increase life expectancy.
Second step in insulin-like signaling pathway; muta-
tions increase life expectancy. 
Pa rtial loss of function increases life expectancy;
caloric restriction mimetic?
Catalyzes renaturation of proteins denatured by heat;
overexpression increases life expectancy. 
Overexpression increases life expectancy; ov e r -
expression need occur only in motor neurons; total
ablation reduces life expectancy.
Pa rtial loss of function increases life expectancy and
resistance to stress.
Overexpression increases life expectancy at high
t e m p e r a t u r e .
Rogina et al. 1997
Tatar et al. 2001
Clancy et al. 2001
Rogina et al. 2000
Tatar et al. 2001
Phillips et al. 1989
Parkes et al. 1998
Sun and Tower 1999
Lin et al. 1998
Jonassen et al. 2001
Chavous et al. 2001
Longevity Genes Identified in Fruit Flies
(Drosophila melanogaster)
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BIOCHEMICAL
GENE FUNCTION COMMENTS REFERENCES
Pit1
dw
Prop1df
Ghr
G h r hrl i t
Klotho
p66shc
Sod2
MsrA
Upa
p53
Transcription 
factor required
for pituitary
development
Required 
for pituitary
development
Growth hormone
receptor
Growth hormone
releasing 
h o rmone receptor
Membrane 
protein with 
β-glucosidase
activity?
Not known 
Mn-superoxide
dismutase
Methionine 
sulfoxide 
reductase 
Urokinase-type
plasminogen
activator 
Tumor 
suppressor 
protein
Mice are deficient in GH, prolactin, and TSH; 
are infertile and cold intolerant, and grow slowly;   
mutations increase life expectancy and delay
immune function and collagen aging.
Mutations increase life expectancy; phenotype
same as pit1dw mice.
Loss of function increases life expectancy; high 
circulating growth hormone levels. 
Have low circulating growth hormone levels and
increased life expectancy.
Mutations lead to arteriosclerosis, osteoporosis,
and reduced life expectancy; mutants appear to be
more insulin sensitive. 
Mutations enhance resistance to apoptosis and
increase life expectancy; phenotype not yet well
characterized.
Mutant mice die very young with evidence of
extreme oxidative stress. 
Converts methionine sulfoxide to methionine on 
the surface of proteins.
Overexpression in the hypothalamus decreases
appetite; caloric restriction mimetic?
Pa rtial deletion of gene leads to premature dev e l op-
ment of age-related pathology and reduced life
expectancy; the +/m mouse is very tumor resistant.
Bartke et al. 2001a, b
Flurkey et al. 2001
Bartke et al. 2001a, b
Coschigano et al. 2000
Flurkey et al. 2001
Kuro-o et al. 1997
Migliaccio et al. 1999
van Remmen et al. 2001
Moskovitz et al. 2001
Miskin and Masos 1997
Tyner et al. 2002
Longevity Genes Identified in Mice
Table 3
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BIOCHEMICAL
GENE FUNCTION COMMENTS REFERENCES
APOE
ACE
PAI1
HLA-DR
WRN
B3AR
MTHFR
KLOTHO
Lipoprotein metabolism 
Angiotensin-converting
enzyme
Plasminogen 
activator inhibitor 1
H i s t o c o m p a t a b i l i t y
locus antigen
Possesses both 
DNA helicase and
exonuclease activity
B-3 adrenergic receptor
5-, 10-methylenetetra-
hydrofolate reductase
Membrane protein with 
β-glucosidase activity?
E2 variant is frequent in centenarians while E4 variant as a
risk factor for Alzheimer’s disease is rare in centenarians.
Plays a role in regulating blood pressure.
Plays a role in blood clotting, thus affecting risk of stroke
and heart attack.
DR variant is frequent in centenarians; resists infection and
inflammation?
Gene responsible for Werner’s Syndrome; mutation leads to
a variety of aging-related pathologies, e.g., cataracts, can-
cer, osteoporosis, slow wound healing, etc.
Allelic form present affects time of onset of Type 2 diabetes.
Deficiency leads to increased levels of homocysteine and
DNA hypomethylation; increases risk of cardiovascular 
disease and cancer.
Homozygous variant form is underrepresented in elderly
individuals.
Schachter et al. 1994
Schachter et al. 1994
Mannucci et al. 1997
Ivanova et al. 1998
Yu et al. 1996
Huang et al. 1998
Martin and Oshima 2000
Walston et al. 1995
Heijmans et al. 2000
Arking et al. 2002
Genes Associated With Avoiding 
Late-Life Disease in Humans
Table 4
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Insulin-Signaling Pathway Stress Resistance           Metabolic Rate
Nematode daf-2 old-1 clk-1
age-1 (daf-23) old-2 eat-1
ctl-1 eat-2
mev-1 sir-2
Fruit fly InR sod1 Indy
chico mth
hsp70
Pcmt
Mouse Pit1dw Sod2 Upa 
Prop1df p66shc (caloric restriction?)
Ghrhrlit MsrA
Ghr p53?
Klotho?
Primates (including humans) PROP1* ? Caloric restriction 
GHR* in primates?≠
Cross-Species Comparisons of Processes and
Genes That Influence Longevity and/or Aging
Table 5
* Human PROP1 and GHRmutations have been identified,but evidence that they increase life expectancy is fragmentary.
≠ Preliminary results suggest that caloric restriction may extend life expectancy in Rhesus monkeys (Wanagat et al. 1999). Although some mutants have pleiotrophic
effects and could be placed in two or more columns,they are listed in the column most relevant to the primary defect.
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NEMATODES (Caenorhabditis elegans)
age-1 was the first single gene mutation shown to
extend life expectancy in any organism (Klass and
Hirsh 1976; Friedman and Johnson 1988). This
was followed by the demonstration by Kenyon et
al. (1993) and Larsen et al. (1995) that
Caenorhabditis elegans daf-2 and daf-23 mutants
a re also lon g - l i ve d . Su b s e q u e n t ly, age-1 and daf-23
were shown to be the same genetic locus based on
their failure to complement (Malone et al. 1996;
Morris et al. 1996).These results were quickly
followed by the identification of other C. elegans
mutations that either increase life expectancy or
modify the extension of life expectancy by 
other mutations (see Table 1).
The next major breakthrough occurred with the
cloning and sequencing of these genes and the
identification of the proteins coded by them. As
seen in Table 1, daf-2 codes for a protein with
homology to the gene family that includes the
insulin receptor in mammals (Kimura et al. 1997),
daf-16 codes for a protein with homology to a
known transcription factor (Ogg et al. 1997; Lin
et al. 1 9 9 7 ) , and age-1 (daf-23) codes for a pro t e i n
with homology to the enzyme phosphatidyl-
inositol 3-kinase (Morris et al. 1 9 9 6 ) . This pro t e i n
is involved in transducing the signal from the
insulin-like receptor to downstream effector 
molecules called Akt kinases. Phosphorylation of
the DAF-16 gene product by Akt kinase activity
inactivates this transcription factor by preventing
its nuclear translocation. A few genes that are
regulated by the DAF-16 gene product have been
described (Yu and Larsen 2001; Murakami and
Johnson 2001).
H ow daf-2 and age-1 (daf-23) genes in C. e l e g a n s
globally influence aging is not known. Even
though the natural ligand for the insulin-like
receptor in C. elegans has yet to be identified,
the a b ove results indicate that this insulin-like 
signaling pathway can influence lon g ev i ty re g u l a t i on .
Of particular interest is the observation that 
normal daf-2 expression need be restored only in
neurons to specify wild-type life expectancy
(Wolkow et al. 2000).
The old-1 and old-2 genes code for putative
receptors with tyrosine kinase activity. Over-
e x p re s s i on of either gene con fers increased re s i s t a n c e
to heat and UV-irradiation (Murakami and
Johnson 1998; Rikke et al. 2000). old-1 and old-2
a re about 90 percent identica l , and these mu t a t i on s
extend life expectancy by 65 percent and 20 per-
cent, respectively (Murakami and Johnson 1998).
In C. elegans, increased life expectancy and
resistance to environmental stress appear to be
closely associated, but how old-1 and old-2
mutants increase stress resistance is not known.
In contrast, the ctl-1 gene codes for cytosolic
catalase activity, and the life expectancy of ctl-1
mutants is decreased by about 25 percent,
presumably because of increased oxidative stress
(Taub et al. 1 9 9 9 ) . The ctl-1 mu t a t i on also preve n t s
the increased life expectancy characteristic 
of daf-2, age-1, and clk-1 mutants.The age-1 
mutation increases the levels of both catalase 
and superoxide dismutase activity in C. elegans
(Larsen 1993), but it is not clear whether this
increased resistance to oxidative stress is required
for the increased life expectancy of the age-1
mu t a n t . Fu rt h e rm o re, ove rp ro d u c t i on of superox i d e
Lessons From Invertebrate 
Model Systems
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anion by mitochondria due to mutations in 
the mev-1 gene shortens life expectancy
(Senoo-Matsuda et al. 2001); mev-1 codes for a
component of the mitochondrial complex II.
Finally, slowing down mitochondrial metabolism
also appears to extend life expectancy in C.
elegans. Clk-1 mutants are slow growing but
long-lived when grown on E. coli (Lakowski and
Hekimi 1996). The clk-1 mutant fails to g row
when coenzyme Q is re m oved from the diet 
altogether because it is unable to syn t h e s i ze coen-
zyme Q9 (Jonassen et al. 2001). Overexpression
of the clk-1 gene shortens life span (Felkai et al.
1999). In contrast, the life expectancy of wild-
type C. elegans is extended about 60 percent by
growth on a diet lacking coenzyme Q (Larsen
and Clarke 2002).There are also many C. elegans
eat mutants with defects in feeding. Most of these
eat mutants are long-lived, presumably because
they mimic caloric restriction; the strongest effe c t
was seen with eat-2, w h i ch lives about 50 perc e n t
l onger than wild type (La k owski and Hekimi
1 9 9 8 ) . The eat-2 mu t a t i on further extends the life
e x p e c t a n cy of daf-2 mutants but not clk-1 mu t a n t s .
In summary, regulation of life expectancy of C.
elegans can be influenced by at least three import a n t
pathways or processes: insulin-like signaling,
stress resistance, and caloric intake/metabolic rate.
These processes overlap to some extent, and all
have putative mammalian parallels (Table 5).
FRUIT FLIES (Drosophila melanogaster)
The discovery that nematode mutants with an
attenuated insulin-like signaling pathway have
increased life expectancy spurred attempts to
determine whether the same would be true 
in fruit flies. Support for this point of view has
been obtained (Tatar et al. 2001), but it is 
not clear why some effects are much greater in
females than in males (Clancy et al. 2001).
Many approaches have been tried to demonstrate
that Cu/Zn-superoxide dismutase (SOD1) plays
a role in aging. Early experiments showed that
mutants lacking SOD1 live only 20 percent 
as long as normal (Phillips et al. 1989). A later
report concluded that overexpression of SOD1
increased life expectancy if accompanied by over-
expression of catalase (Orr and Sohal 1994), but
concerns about the life expectancy of the control
strain compromise this interpretation. Parkes et
al. (1998) found that selective overexpression of
the human SOD1 gene alone in motor neurons
increases life expectancy, and Sun and Tower
(1999) reported that overexpression of the fruit fly
sod1 gene in all cells is positively correlated with
life expectancy. Although the molecular basis 
for the extended life expectancy of the flies selected
by Rose (1984) is unknown, these long-lived flies
are resistant to oxidative stress in the form of
superoxide anion (Harshman and Haberer 2000).
In view of these diverse results, the conclusion
that sod1 is a longevity gene remains equivocal.
Another possible example is the gene that codes
for the repair enzyme protein carboxyl methyl-
transferase (PCMT). PCMT converts isoaspartyl
residues back to aspartyl residues, and isoaspartyl
residues accumulate in proteins with age if PCMT
is absent in mice. When this enzyme is overex-
pressed in fruit flies at a high temperature (29ºC),
mean life expectancy is increased by about 35 
percent (Chavous et al. 2001).This enzyme 
presumably helps to maintain appropriate protein
structure and function during aging in a variety
of organisms, and its activity may be rate limiting
in fruit flies stressed by growth at 29ºC.
Research on fruit flies has identified several new
longevity genes.These include (a) the methuselah
(mth) gene that codes for a putative transmem-
brane signal transduction protein whose specific
role in vivo is unknown, although these mutants
h a ve increased resistance to stress (Lin et al. 1 9 9 8 ) ,
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and (b) a gene coding for a dica rb ox ylic acid 
t ra n s p o rt protein that is con s e rved in mammals and
C. elegans (Rogina et al. 2000). This transport
protein may be required for uptake of citric acid
cycle intermediates such as succinate, citrate,
and a-ketoglutarate by the mitochondria. In the
mutant called Indy (I’m not dead yet), partial
decreases in this transporter protein significantly
increase life expectancy without a significant
change in either reproduction or physical activity.
This mutation is particular ly interesting because
of its possible relevance to the mechanistic basis
of caloric restriction. Rogina et al. (2000) suggest
that “these mutations may create a metabolic state
that mimics caloric restriction, which has been
shown to extend life-span.” Another way to
extend life expectancy is to overexpress the hsp70
gene, which codes for a heat-shock protein (Tatar
et al. 1997). Such proteins are assumed to increase
survival by preventing denaturation of proteins in
response to stress.
The mth and Indy mutations are both partial
l o s s - o f - f u n c t i on mu t a t i on s , suggesting that norm a l
levels of these proteins are not optimal for 
l i fe expectancy. These genetic interve n t i ons cl e a rly 
are not examples of supplementation of proteins
or functions lost during aging, and knowledge 
of the physiological functions they alter might
lead to the development of nongenetic interven-
tions that could be useful in people.
Rogina et al. (1997) have also described a short-
l i ved fruit fly mutant ca lled drop-dead that appears
to age prematurely and rapidly, as judged by 
patterns of age-related changes in gene expre s s i on .
The life expectancy of the mutant is only about
20 percent of normal, though the reason for this
accelerated aging is not known. Helfand et al.
(1995) have identified a number of genes having
temporal expression patterns in antenna that 
scale with life span, but most of these have not
been further characterized, and it is not yet clear
whether the temporal pattern of gene expression
is a biomarker of aging in Drosophila.
In summary, regulation of life expectancy in 
fruit flies may be influenced by attenuation of the
insulin-like signaling pathway and/or metabolic
rate and is associated with stress resistance,
all of which mirror the findings with nematodes
(Tables 2 and 5).
YEAST (Saccharomyces cerevisiae)
Although yeast was not discussed at the work-
shop, it is briefly included here because of a
unique life-extending process uncovered by
Leonard Guarente’s laboratory (Tissenbaum and
Guarente 2001). In yeast, the SIR2 gene codes 
for a histone deacetylase activity that silences
gene expression, and overexpression of this gene
extends life span of not only yeast but also C.
elegans. The histone deacetylase activity requires
NAD+ as a cofactor, establishing a possible link
between increased life expectancy and nutrient
availability. Mutations in the Akt protein 
kinase gene SCH9, which operates in the insulin 
signaling pathway, also extend life span 
and increase stress resistance in yeast (Fabrizio 
et al. 2001).
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Because of their more complex anatomy and our
better knowledge of their physiology and metabo-
lism, mice provide a very useful model system for
a bridge between invertebrates and humans.
At least four distinct genes (Pit1dw, Pro p 1d f, G h r,
G h rhrl i t) have been identified in which loss-of-
f u n c t i on mu t a t i ons lead to dwarfism and increased
mean and maximum longevity (Table 3). These
all affect either the production of growth 
hormone or the ability to respond to it, and the
first three have been shown to reduce the levels of
circulating IGF-I, insulin, and body temperature
(Bartke et al. 2001a). All of these dwarf mice 
live longer than normal, in agreement with results
found in nematodes and fruit flies. Of con s i d e ra b l e
interest is the observation that caloric restriction
further increases the life expectancy of Prop1df
dwarf mice (Bartke et al. 2001c), suggesting 
that the mechanism by which these two pathways
influence the rate of aging may be at least 
partially distinct.
M a ny genetica lly altered mice have been genera t e d
to determine whether enzymes inv o lved in either
p reventing or re p a i ring damage to cellular com p o-
nents (such as pro t e i n s , D NA , and membra n e s )
p l ay cri t i cal roles in aging. Fo remost among these
a re DNA repair enzymes and antioxidant enzym e s ,
s u ch as superoxide dismu t a s e, ca t a l a s e, g l u t a t h i on e
p e rox i d a s e, and methionine sulfoxide re d u c t a s e .
H ow eve r, s ome genetic interve n t i ons that extend
l i fe expectancy in inve rt e b ra t e s , s u ch as SOD1
ove re x p re s s i on in fruit flies, a p p a re n t ly do not have
the same effect in mice (Huang et al. 2 0 0 0 ) . I n
c on t ra s t , mice totally deficient in the mitoch on d ri a l
s u p e roxide dismutase 2 activity are extre m e ly 
v u l n e rable to ox i d a t i ve stress because mitoch on d ri a
a re the pri m a ry site of genera t i on of re a c t i ve ox y g e n
species in vivo (Li et al. 1 9 9 5 ) . Su ch mice die 
within 30 days after birt h , depending on their
genetic back g ro u n d , but it is unlikely that studyi n g
s u ch mice will provide mu ch inform a t i on about
n o rmal aging because of their extreme ox i d a t i ve
s t ress and ve ry early death. A more benign,
but still prematurely fatal, intervention is to ablate
methionine s u l f oxide reductase activity; the life
e x p e c t a n cy of these mice is about 40 percent less
than normal (Moskovitz et al. 2 0 0 1 ) , s u g g e s t i n g
that deficiency of this enzyme com p romises pro t e i n
s t ru c t u re and function and thereby affects the ra t e
of aging. The p66s h c mu t a t i on occurs in a gene that
codes for a signal transduction protein that 
regulates apoptosis in re s p onse to ox i d a t i ve stre s s ,
and in so doing extends life expectancy (Migliaccio
et al. 1 9 9 9 ) . An interesting short - l i ved mouse
model was re c e n t ly re p o rted by Tyner et al. ( 2 0 0 2 ) .
This hetero zy gous mouse ca r ries one good allele 
of the p53 gene and one tru n ca t e d , but still active,
a llele of p53. These mice are ve ry cancer re s i s t a n t
but also develop age-related pathologies (e.g. ,
o s t e o p o ro s i s , loss of subcutaneous fat, reduced ra t e
of wound healing, mu s cle atro phy) and die soon e r
than usual. Another interesting but ve ry short - l i ve d
mutant is the klotho mouse that exhibits a similar
syndrome resembling human aging (e.g., osteo-
porosis, atherosclerosis, skin atrophy) and dies by
10 weeks of age (Kuro-o et al. 1997).The klotho
gene is hom o l o gous to a gene for a putative mem-
b rane protein with β-glucosidase activity. H u m a n s
Lessons From a Mammalian 
Model System
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with polym o rphisms in this gene are know n , a n d
h om o zy gous individuals with two variant alleles 
of this gene are underre p resented in the elderly
p o p u l a t i on (Arking et al. 2 0 0 2 ) .
A genetic interve n t i on that appears to mimic ca l o ri c
re s t ri c t i on is ove re x p re s s i on of the gene coding 
for the urokinase type of plasminogen activator in
the hyp o t h a l a mu s . This appare n t ly dow n - re g u l a t e s
a p p e t i t e, leading to lower food intake and small e r
body size (Miskin and Masos 1997).
In summary, putative parallels have been observed
among nematodes, fruit flies, and mice, assuming
that the growth hormone-related mutations act 
by reducing insulin-like signaling in mice (Table
5). At least some of nematode, fruit fly, and
mouse mutations may mimic changes induced in
mice by caloric restriction.
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MAJOR QUESTIONS ARISING FROM THESE
STUDIES WITH ANIMAL MODELS:
• Can these results be extrapolated to humans?
• If so, will this information lead to the 
development of safe and effective nongenetic
interventions to delay some of the adverse
aspects of aging in humans, or at least provide
clues about modulating mechanisms of 
aging in humans?
• What other genes can be mutated or overex-
pressed to produce delayed aging, and does 
natural variation at these loci influence the rate
of aging and risk of late-life diseases in mice?
• Most important, do any of the loci where
null mutations greatly extend longevity in model 
systems provide leads to the genetic differences
responsible for the much greater aging rate 
differences among species?
One example of the difficulty encountered in
comparing the effect of natural human mutations
with targeted mouse mutations is provided by 
the growth hormone receptor gene (GHR).
Humans lacking growth hormone receptor 
function are known, and these Laron syndrome
patients are ch a ra c t e ri zed by short stature, f a c i a l
d ys m o rph i s m , obesity, low serum glucose and
IGF-I, and delayed puberty (Zhou et al. 1997).
More than 220 cases have been reported 
so far, but these represent at least 25 different
mutations (partial gene deletions and nonsense
and missense point mutations), so there are
also various phenotypes (Kopchick and Laron
1999). Furthermore, longevity data on these
human cases appear to be sca rc e . The oldest
patient with La ron syn d rom e in the Israeli coh o rt is
only 70 years old. However, fragmentary informa-
tion for the “Little People” of Krk with mutations
in the PROP1 gene suggest that these individuals
may be long-lived (Krzisnik et al. 1999; Bartke 
et al. 2 0 0 1 a ) ; at least one patient lived for 91
ye a r s . T h u s , while either complete growth 
hormone deficiency or the inability to respond to
g rowth horm one might not be the optimal 
s t ra t e gy for manipulating life expectancy and
aging in humans, it is at least possible that 
m o d e rate depre s s i on of circulating growth 
h o rm one and IGF-I levels at early ages might
lead to lower risk of age-related diseases at older
ages. Such a preventive strategy would most 
likely involve direct manipulation of the IGF-I
signaling pathway by nongenetic interventions.
H ow eve r, although decreased insulin-like signaling
appears to increase life expectancy in inve rt e b ra t e s ,
similar mutations in humans might cause insulin
re s i s t a n c e, w h i ch would be life short e n i n g. It is 
not clear how to re s o lve this interspecies dich o t om y.
Although the exact number of human genes
remains in dispute, it is known that there
are substantially more than exist in the inverte-
brate species discussed in Lessons From
Invertebrate Model Systems (p. 10). Because
humans have much longer life expectancy and 
a much more complex physiology, and because
invertebrate species are not known to die from 
w e ll - ch a ra c t e ri ze d pathology and disease, the 
spectrum of identifiable human longevity genes
may differ substantially from those shown in
Transition From Animal 
Models to Humans
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Tables 1 and 2. It is also likely that the genetics of
longevity in humans is much more complex than
in invertebrate species. Furthermore, age-related
pathology clearly differs in mice and humans,
so even murine and human longevity genes 
may have limited overlap. Seemingly, this might 
discourage one from engaging in a search for
longevity genes in humans, but several recent 
discoveries, coupled with advances in genetics and
genomics technology and progress made on the
Human Genome Project, could greatly accelerate
the search for human longevity genes.The 
following section describes current efforts to 
identify human longevity genes. It is already clear 
that many genes associated with avoiding late-life
disease will be discovered (Table 4), and these 
will provide valuable information for reducing
age-related disease and pathology.
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WHO SHOULD BE SELECTED AS SUBJECTS
FOR THE DISCOVERY OF HUMAN 
LONGEVITY GENES? 
Some success has been achieved in identifying
genes that increase the risk of early - l i fe pathology
or that affect what kind of old person one
becomes. One approach to detect such gene 
variants is to determine their frequency at older
ages in cross-sectional studies (Schachter et al.
1994); the “oldest old” or centenarians may
be the best subjects for such longevity research.
Although 100 years of age has no special geronto-
logical significance, many studies have arbitrarily
used this milestone in their design. These studies
have produced the following results:
• Several studies have shown a very strong relative
risk (fourfold to seventeenfold) among siblings
of centenarians for becoming a centenarian
(Kerber et al. 2001; Gudmundsson et al. 2000;
Perls et al. 1998). Such relative risks, especially
those greater than eight, are consistent with 
an important genetic component to exceptional
longevity (Rybicki and Elston 2000).
• The proportion of people who reach age 100 is
only about 1 per 5,000–10,000, and thus the 
trait is less common than many other complex
syndromes with genetic underpinnings, such
as type 2 diabetes.
• Centenarians usually maintain good health to
ve ry old ages. Most centenarians re p o rt minimal
or no medical expenses through seven or more
decades of life, even though centenarians often  
d i s close unhealthy life s tyle practices (e.g. , o b e s i ty
and cigarette smoking) and usually indicate no
overt effort to achieve longevity, suggesting a
genetic rather than an env i ron m e n t a l disposition
to exceptional longevity.
• Centenarians typically have shorter periods of
morbidity than people who die at younger ages
(Hitt et al. 1999).
WHAT RECRUITMENT STRATEGIES 
SHOULD WE USE?
Although centenarians appear to be enriched 
with longevity genes, investigators face significant
challenges in recruiting large numbers of such
individuals for genetic studies. Traditionally, gene
localization efforts have utilized families in which
several members share the exceptional longevity
trait. However, recruitment from founder 
populations that are more genetically homoge-
neous offers the advantage that fewer genes may
be responsible for longevity and thus they may
be easier to identify. A second challenge is that
although age of death is an obvious endpoint 
for study, unequivocal biomarkers (or intermediate
traits) relevant to aging and longevity in humans
have not been identified (International Longevity
Center 2001).
EFFECTIVE ASCERTAINMENT STRATEGIES FOR
LONGEVITY GENE LOCALIZATION EFFORTS 
• R e c ruitment of centenarians and their lon g - l i ve d
(affected) siblings for affected sib-pair linkage
analysis.
Identifying Human Longevity Genes
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• Recruitment of long-lived multigenerational
multiplex families for linkage analysis (both
parametric and model-free).
• Recruitment of large numbers of unrelated 
long-lived individuals and ethnical ly matched
“controls” for association analyses.
• Recruitment of the offspring and spouses of
long-lived probands in order to identify and
measure biomarkers of the longevity phenotype
for quantitative trait linkage analysis and 
also for candidate gene studies. These individuals
may also be useful for longitudinal follow-up.
WHAT GENETIC APPROACHES CAN BE USED
TO IDENTIFY HUMAN LONGEVITY GENES?
The two main approaches that are utilized to
identify genes for diseases and other traits,
including longevity, are the candidate-gene and
the genome-wide approaches.The candidate-gene
approach requires knowledge of the under lying
biology of the age-related trait and, based upon
this understanding, identification for study of
those specifica lly inv o lved in the underlying 
b i o l o g i cal pro c e s s e s .The candidate gene is examined 
for sequence variants (mutations and single
nucleotide polymorphisms). If a gene variant is
found, one may then determine whether the gene
variant is shared more often in pairs of long-lived
siblings or tracks with longevity in families (link-
age analysis). Alternatively, one can ask whether
the identified gene variant is more common in
l on g - l i ved individuals than in con t rols 
( a s s o c i a t i on analys i s ) . Once an association or 
linkage of the gene variant with lon g ev i ty is
d e m on s t ra t e d , studies to investigate how 
the variant alters function , and how the altered 
f u n c t i on leads to exc e p t i onal lon g ev i ty, a re 
p e rf o rm e d . Candidate genes might incl u d e
those whose products are inv o lved with lipopro-
tein metabolism, ox i d a t i ve stre s s , D NA re p a i r,
c e ll death, insulin resistance, and metabolism.
However, given our very limited understanding of
the aging process, our choices of which candidate
genes to study are no more than educated guesses.
The candidate-gene approach can also be applied
to the mitoch on d rial genome as well as the nucl e ar
genome. For example, Tanaka et al. (2000) have
identified a longevity-associated polymorphism in
the gene coding for NADH dehydrogenase, a
component of the mitochondrial complex I.The
mutant form of this gene suppresses the accumu-
lation of mitochondrial DNA mutations and is
enriched in centenarians, possibly because it
reduces oxidative stress-induced mutagenesis.
This is likely to increase resistance to adult-onset
diseases caused in part by age-related mitochon-
drial dysfunction.
With the progress of the Human Genome
Project, it is now possible to perform a search
throughout the entire genome (nuclear and 
mitochondrial) to find regions of chromosomes
that are shared more often in long-lived family
members than would be expected by chance.
The elegance of this approach is that it makes no
a priori assumptions about biological processes 
or candidate genes. Once a chromosomal region
is localized, the genes in that region can be 
examined for mu t a t i on s . Once a gene is identified,
linkage analysis and/or association analyses can be
performed; and if the gene variant associates or is
linked to longevity, then functional studies, as
outlined above, can be performed.
CURRENT EFFORTS AND SUCCESSES
Some pro g ress has already been made in re c ru i t i n g
and studying long-lived individuals and their 
siblings for genetic analyses. For example, the
New England Centenarian Study has recruited
250 long-lived sibling pairs from throughout 
the United States. As mentioned above, there
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are advantages to performing studies in more
genetically homogeneous populations. To this
end, researchers are now collecting and studying
long-lived individuals and their family members
f rom the Ashkenazi, Amish (Mitch e ll et al. 2 0 0 1 ),
and Sardinian populations. Also, a genome-wide
scan for linkage to human exceptional longevity
was performed among 308 long-lived individuals
comprising 137 families recruited for the New
England study. One region of the genome that
the sibling pairs shared more than would be
expected by chance was on chromosome 4 (Puca
et al. 2001).The next step in this research is to
define which of the many genes in this region is
linked to exceptional longevity.
T h rough use of high-throughput genomics 
t e ch n o l o gy, large numbers of gene vari a n t s
t h roughout the human genome have been 
investigated for over- or underrepresentation in
unrelated individuals of varying ages. Several gene
variants have been identified with this approach,
and the relevance of gene variants to age-related
disease and the aging process is now under 
investigation. Centenarians may represent an
“ideal genom e” in terms of lacking genetic vari a n t s
that predispose them to age-related diseases at
younger ages. As such, the frequencies of 
informative single nucleotide polymorphisms
could be compared between centenarians and
individuals with specific age-related diseases, thus
aiding in the discovery of disease-disposing genes.
Some pro g ress has been made in defining age-sen-
s i t i ve traits associated with successful aging. Wh i l e
most biological parameters in centenarians at the end
of life are in the normal ra n g e, it does not necessari ly
mean that this was the case when they were 30
years yo u n g e r. I n d e e d , w h e reas high-density
l i p o p rotein (HDL) ch o l e s t e rol levels in Ashkenazi
c e n t e n a rians are norm a l , HDL ch o l e s t e rol levels in
o f fs p ring of centenarians (some of whom also are
e n ri ched for lon g ev i ty genes) are mu ch higher than
an age-matched coh o rt . The pattern of inheritance 
of high HDL cholesterol appears to be autosomal
d om i n a n t . It is likely that their centenarian pare n t s
also had high HDL ch o l e s t e rol levels earlier in
adult life and that, although HDL ch o l e s t e rol leve l s
d e c reased into the normal range over time, t h i s
“b i om a rk e r” either dire c t ly protected the individual
f rom killing diseases (e.g. , ca rd i ovascular disease) or
was a marker for other biological traits that
enhanced lon g ev i ty (Barzilai et al. 2 0 0 1 ) .C a n d i d a t e-
gene appro a ches in which genes that are inv o lved 
in the re g u l a t i on of HDL ch o l e s t e rol levels 
might unveil gene variants that promote lon g ev i ty.
FUTURE DIRECTIONS AND 
RECOMMENDATIONS FOR HUMAN 
GENETIC RESEARCH
T h e re is convincing evidence that human lon g ev i ty
has a genetic component (Finch and Tanzi 1997;
Ljungquist et al. 1998). Recent progress in 
identif ying lon g ev i ty genes in animal models, t h e
s u c c e s s of the Human Genome Project, and 
the development of improved genetic and genom i c s
t e ch n o l o gy should make it possible to identify
l on g ev i ty genes in humans also. These factors justify
m ov i n g human longevity research forward in 
parallel with research in animal model systems.
Success of the effort will depend on:
• Recruitment and characterization of large 
numbers of long-lived individuals and their 
family members.
• Use of genome-wide and candidate-gene
approaches.The former requires access to 
high-throughput genomics technology, while
the latter requires increased knowledge of 
biological processes of aging and disease.
• Defining human longevity biomarkers (probably
through the study of offspring of long-lived
individuals).
• Investigation of how genes interact with envi-
ronmental factors such as physical activity, diet,
and other exposures.
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The previous sections have documented the 
enormous advances made in the past 10 years 
to identify genes and processes that influence
longevity in both animal model systems and
humans. Research on invertebrates has been 
particularly successful because of their short life
spans and well-developed genetic systems. The
good news is that apparent parallels have already
been demonstrated between invertebrates and
mammalian systems, including, to a very limited
extent, humans. However, it is important to note
that the goal of these studies is not to find ways of
altering human genes but to learn enough about
aging to extend the years of active healthy life 
without genetic alterations. The ultimate payoff for
genetic research is to learn enough about aging 
to identify promising avenues for nongenetic
interventions to delay, prevent, or even reverse 
the adverse age-related changes leading to disease
and disability. With this in mind, the workshop
participants identified the following avenues for
future research, in addition to those listed in the
previous section:
• Caloric Restriction (CR) 
The molecular mechanisms by which caloric
restriction increases healthy life expectancy must
be understood. Although it would be useful to
know whether CR increases the life expectancy
of humans and other primates, how CR delays
age-related disease in rodents is also an impor-
tant intermediate goal. Similar arguments can be
made for understanding the roles of the insulin-
like signaling pathways and stress resistance in
regulating life expectancy.
• Identify Biomarkers of Aging 
This need was discussed in a Canyon Ranch
report (International Longevity Center 2001).
Success would provide an important tool for 
validating promising interventions as well
as characterizing longevity genes.
• Comparative Biology of Aging 
The promise of this approach is consistent with
the results summarized in Table 5. Increased
emphasis should be given to understanding how
some species either escape aging or appear to 
be longer-lived than expected based on known
physiological parameters. For example, it would
be useful to know how most bird species deal
with high circulating glucose levels, body 
temperature, and metabolic rate, all of which are
thought to be risk factors for aging.
• Use of Mammalian Models 
Invertebrate model systems such as nematodes
and fruit flies have been extremely useful 
for identifying genes that influence aging and
longevity, but it is important to increase the
emphasis on mammals, including nonhuman
primates, in future research. Possibilities incl u d e
the lemur and, b e cause of available c o l onies in 
the United St a t e s , b a b o ons and rh e s u s monkeys.
• Single Nucleotide Polymorphisms
The elucidation of the sequence of the human
g e n om e, and subsequent resequencing of selected
genes in a population of individuals, indicates
that there is great genetic diversity among 
individuals. It is a high priority to continue the 
Research Agenda
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search for alleles in candidate genes that
significantly influence the rate of aging and life
expectancy and the risk for age-related disease.
• Environmental Factors 
Genetic factors have been estimated to account
for at most 30 percent of human risk factors in
aging (Ljungquist et al. 1998).The remaining
risk is likely due to env i ronmental and behaviora l
factors, so it is important to identify these and
h ow they interact with the known genetic factors.
An example is the role of exercise in aging.
• Drug Discovery
The translational value of understanding the
genetic basis of aging and longevity is to 
i n c rease the potential for ra t i onal drug discove ry
related to reducing the incidence and/ o r
delaying the onset of age-related disease.
T h u s , e m phasis should be placed on tra n s l a t i on a l
research leading to discovering useful drug
interventions to improve the health of older
people and to prevent disability.
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Glossary
ALLELE – one of the variant forms of a gene 
at a particular locus on a chromosome. Different
forms of a gene (one from each parent) produce
variation in inherited characteristics.
A L Z HEI M ER’S DISEASE – an aging-dependent
disease characterized by loss of memory. Risk 
factors include both genetic and environmental
factors. Age of onset varies from the late forties
for patients with ear ly-onset genetic risk factors
to 65 and older for most other patients.
ANTIOXIDANT – a compound and/or enzyme
that neutralizes reactive oxygen species, thereby
reducing oxidative stress.
A P O PTO S I S – pro g rammed cell death, the body’s
n o rmal method of disposing of damaged, u nw a n t e d ,
or unneeded cell s . In genera l , apoptosis is the re s u l t
of ox i d a t i ve stress and free ra d i cal damage.
BIOMARKER (OF AGING) – an age-related
change that reflects the physiological age of an
individual in contrast to the chronological age.
CA LO RIC RES T RI C TI O N – a diet stra t e gy to
limit ca l o ric intake while supplying all essential
d i e t a ry ingre d i e n t s . This extends life expectancy and
d e l ays the onset of age-related disease in ro d e n t s .
CATALASE – an antioxidant enzyme that 
converts hydrogen peroxide to water and oxygen,
which are less damaging.
CENTENARIAN – a person who has lived for at
least 100 years.
CHROMOSOME – a threadlike package of
genes and other DNA in the nucleus of a cell.
Humans have 23 pairs of chromosomes; each
parent contributes one chromosome to each pair.
DEACETYLASE – an enzyme that removes
acetyl groups from molecules.
daf – a class of genes in nematodes in which
mutations cause developmental defects.
DELETION MUTATION – mutation in which
a portion of a gene has been removed or lost.
DNA – deoxyribonucleic acid, the double-helix
chain that makes up chromosomes and carries the
genes and other genetic instructions for making
living organisms.
FOUNDER POPULATION – a population
in which certain mutations or alleles occur 
frequently because of a shared single ancestor or 
a small number of ancestors.
GENOME – all the DNA contained in an organ-
ism or a cell, including the DNA in chromosomes
within the nucleus and the DNA in mitoch on d ri a .
GENE – functional and physical unit of heredity
passed from parent to offspring. Humans have
two copies of each gene—one inherited from the
mother and one from the father. Genes are loca t e d
at specific places on each of an individual’s 46
chromosomes (23 pairs). Genes are pieces of
DNA, and most genes contain the information
for making a specific protein.
GENETIC LOCUS – the place on a ch rom o s om e
where a specific gene is located.
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GENOTYPE – an individual’s genetic character-
istics as opposed to outw a rd phys i cal ch a ra c t e ri s t i c s
(see ph e n o typ e ) .
GLUTATHIONE – a natural antioxidant made
in cells that helps prevent oxidative damage.
GLUTATHIONE PEROXIDASE – an antioxi-
dant enzyme that uses glutathione to prevent or
reverse oxidative damage.
GROWTH HORMONE – a hormone produced
in the pituitary that is essential for normal
growth; circulating levels decrease with age, and
growth hormone replacement has been promoted
as a possible “anti-aging” intervention.
GROWTH HORMONE RELEASING 
HORMONE – a hormone that directs the 
pituitary gland to produce growth hormone.
HETEROZYGOUS – having two different 
alleles of a gene, one inherited from each parent.
HOMOZYGOUS – having two identical alleles
of a gene, one inherited from each parent.
HORMONE – a substance produced in one 
tissue but usually acting on another.
HUTCHINSON-GILFORD SYNDROME –
a human syndrome characterized by abnormal
development and premature vascular disease.
Children usually die of heart attacks before
reaching the age of 20.
INSULIN-LIKE GROWTH FACTOR I 
(IGF-I) – a factor that resembles insulin and
stimulates cell growth.
INSULIN-LIKE SIGNALING PATHWAY –
the series of biochemical events that occur inside
the cell when insulin binds to its receptor on the
cell surface.
KINASE – an enzyme that catalyzes addition
of a phosphate group to another molecule, often
another protein.
KNOCK-OUT (MOUSE) – d i s ru p t i on or deletion
of a specific genetic locus from the mouse
genome. Genes can also be “knocked out” in
nematodes and fruit flies.
LIFE EXPECTANCY – the average length of life
of a population of individuals.
LIFE SPAN – the maximum life span defines 
the age of death of the longest-lived member of 
a population.
LIGAND – a molecule that binds to a receptor
and initiates a specific signaling pathway inside
the cell. Hormones are examples of ligands.
METHIONINE – a sulfur containing amino acid
vulnerable to oxidation, resulting in the 
production of methionine sulfoxide.
METHIONINE SULFOXIDE REDUCTASE –
an antioxidant enzyme that converts methionine
sulfoxide back to methionine, including on the
surface of proteins.
MISSENSE MUTATION – the mutation results
in a change in the structure of the protein coded
by the gene.
MITOCHONDRIA – the energy-producing
power plants of cells. Cellular degeneration may
be caused by mitochondrial dysfunction due to
oxidative stress.
MUTATION – a permanent structural alteration
in DNA; an individual carrying a mutation is
referred to as a mutant.
NEMATODE – a microscopic worm, usually soil
dwelling, that has been developed for biomedical
research because of its well-characterized devel-
opmental program; it is a useful model system for
studying aging because of its short life expectancy.
NONSENSE MUTATION – the mutation
results in a protein shorter than the normal 
protein because of premature termination during
synthesis of the protein.
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OSTEOPOROSIS – an age-related pathology
characterized by decreasing bone density leading
to susceptibility to bone fracture.
OXIDATIVE STRESS – the process whereby
cellular macromolecules are damaged by reactive
oxygen species, produced mainly in the mitochon-
dria, leading to dysfunction.
PHEN O TY PE – the observable traits or ch a ra c t e r-
istics of an organism; the ph e n o type is determ i n e d
by the combination of the genotype and environ-
mental factors to which the individual is exposed.
PITUITARY – a gland in the brain that produces
several hormones, including growth hormone.
SARCOPENIA – an age-related pathology
characterized by loss of muscle mass and strength.
SIGNAL TRANSDUCTION – the general term
for a biochemical pathway that transmits the
response to a biological stimulus.
S I N G LE N U C LE O TI D E P O LY M O R PHI S MS –
single base changes in genetic sequences that 
usually have only subtle, if any, effects on the
function of the protein coded by the gene. Every
gene contains such polymorphisms, which can 
be used as genetic markers.
SUPEROXIDE DISMUTASE (SOD) – an
antioxidant enzyme that converts the superoxide
anion to hydrogen peroxide.
SYNDROME – the group of symptoms that
occur together to characterize a particular 
abnormal condition.
TRANSGENIC (MOUSE) – an experimentally
produced mouse, in which DNA has been 
artificially introduced and incorporated into the
mouse’s germ line, usually by injecting the foreign
DNA into the nucleus of a fertilized embryo.
Transgenic nematodes and fruit flies can also be
produced.
TRANSCRIPTION FACTOR – a protein that
helps specify which genes will be expressed at any
given time or in response to a biological stimulus.
WERNER’S SYNDROME – a human 
syndrome characterized by premature age-related
pathologies, usually starting in one’s twenties.
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